Skip to main content
logo
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)
Singapore flag Singapore · Delayed Price · Currency is SGD · Price in USD
3.230
+0.060 (1.89%)
At close: Dec 5, 2025

Revenue by Product

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2003 - 2019
Chinese Patent Medicine
5.66B
Log In
Log In
Log In
Log In
Upgrade
Chinese Patent Medicine Growth
-3.07%
Log In
Log In
Log In
Log In
Upgrade
Western Medicine
1.19B
Log In
Log In
Log In
Log In
Upgrade
Western Medicine Growth
-29.75%
Log In
Log In
Log In
Log In
Upgrade
Other Business
14.25M
Log In
Log In
Log In
Log In
Upgrade
Other Business Growth
-12.24%
Log In
Log In
Log In
Log In
Upgrade
Other
443.15M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-34.16%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2003 - 2019
China
7.26B
Log In
Log In
Log In
Log In
Upgrade
China Growth
-11.09%
Log In
Log In
Log In
Log In
Upgrade
Overseas
36.73M
Log In
Log In
Log In
Log In
Upgrade
Overseas Growth
-18.15%
Log In
Log In
Log In
Log In
Upgrade